Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
F-18 NaF PET/CT for Assessing Radiation-Induced Vascular Complications in Head and Neck Cancers
NCT06914999Phase 1Recruiting
- Sponsor
- Emory University
- Start
- Dec 2024
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial of sodium fluoride f-18 in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by Emory University. Primary endpoints: Radiation-induced vascular complications up to 6 months, Radiation-induced vascular inflammation following IMRT or IMPT up to 6 months and 1 more. Started Dec 2024; status: recruiting.
02
Drugs
sodium fluoride f-18
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT06914999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06914999.